Global Infectious Diseases Market – Industry Trends and Forecast to 2027

  • Healthcare
  • Upcoming Report
  • May 2020
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Infectious Diseases Market By Product & Services (Assays, Kits & Reagents, Instruments, Services & Software), Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), DNA Microarray, Other Technologies), Disease Type (Hepatitis, Human Immunodeficiency Virus (HIV), Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG), Hospital-Acquired Infections (HAIS), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, Other Infectious Diseases), End User (Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other End Users), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027

Infectious Diseases Market

Market Analysis and Insights: Global Infectious Diseases Market

Infectious diseases market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to growing at a CAGR of 7.0% in the above-mentioned forecast period. The growing awareness amongst the physicians and patients regarding the benefits of diagnostics will help in boosting the growth of the market.

Surging volume of patients suffering from infectious diseases, growing preferences of people to shift their focus from centralised laboratories to point of care testing, increasing levels of investment for further research and development activities, growing advancement in genomics and proteomics will likely to enhance the growth of the infectious diseases market in the forecast period of 2020-2027. On the other hand, rising awareness among the people regarding personalised medicine along with rising applications from developing economies which will further boost various opportunities that will lead to the growth of the infectious diseases market in the above mentioned forecast period.

Unfavourable reimbursement policies of the insurance companies along with high cost of healthcare will hamper the growth of the infectious diseases market in the above mentioned forecast period.

This infectious diseases market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on infectious diseases market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Infectious Diseases Market Scope and Market Size

Infectious diseases market is segmented on the basis of product & services, technology, disease type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on product & services, infectious diseases market is segmented into assays, kits & reagents, instruments, and services & software.
  • On the basis of technology, infectious diseases market is segmented into immunodiagnostics, clinical microbiology, polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), DNA sequencing & next-generation sequencing (NGS), DNA microarray and other technologies.
  • Based on disease type, infectious diseases market is segmented into hepatitis, human immunodeficiency virus (HIV), chlamydia trachomatis genital infection and gonorrhea (CT/NG), hospital-acquired infections (HAIS), human papillomavirus (HPV), tuberculosis (TB), influenza and other infectious diseases.
  • Infectious diseases market has also been segmented based on the end user into hospital/clinical laboratories, reference laboratories, physician offices, academic/research institutes and other end users.

Infectious Diseases Market Country Level Analysis

Infectious diseases market is analysed and market size insights and trends are provided by country, product & services, technology, disease type and end user as referenced above.

The countries covered in the infectious diseases market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the infectious diseases market due to the high prevalence of improved healthcare infrastructure along with increasing occurrences of infectious diseases, adoption of advanced technology and rising number of clinical laboratories.

The country section of the infectious diseases market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Infectious diseases market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for infectious diseases market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the infectious diseases market. The data is available for historic period 2010 to 2018.Competitive Landscape and Infectious Diseases Market Share Analysis

Infectious diseases market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to infectious diseases market.

The major players covered in the infectious diseases market report are Abbott Laboratories, BD, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher., DiaSorin S.p.A., Luminex Corporation, Meridian Bioscience, Inc., Quidel Corporation., F. Hoffmann-La Roche Ltd, Siemens, Thermo Fisher Scientific Inc., OraSure Technologies, Inc., Hologic Inc. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: Global Infectious Diseases Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19